These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38139233)

  • 1. Recent Advances in the HPPH-Based Third-Generation Photodynamic Agents in Biomedical Applications.
    Fan L; Jiang Z; Xiong Y; Xu Z; Yang X; Gu D; Ainiwaer M; Li L; Liu J; Chen F
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy.
    Lobel J; MacDonald IJ; Ciesielski MJ; Barone T; Potter WR; Pollina J; Plunkett RJ; Fenstermaker RA; Dougherty TJ
    Lasers Surg Med; 2001; 29(5):397-405. PubMed ID: 11891727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
    Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
    Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photosensitizer loaded nano-graphene for multimodality imaging guided tumor photodynamic therapy.
    Rong P; Yang K; Srivastan A; Kiesewetter DO; Yue X; Wang F; Nie L; Bhirde A; Wang Z; Liu Z; Niu G; Wang W; Chen X
    Theranostics; 2014; 4(3):229-39. PubMed ID: 24505232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.
    Furukawa K; Yamamoto H; Crean DH; Kato H; Mang TS
    Lasers Surg Med; 1996; 18(2):157-66. PubMed ID: 8833284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy.
    Wang S; Fan W; Kim G; Hah HJ; Lee YE; Kopelman R; Ethirajan M; Gupta A; Goswami LN; Pera P; Morgan J; Pandey RK
    Lasers Surg Med; 2011 Sep; 43(7):686-95. PubMed ID: 22057496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling.
    Penjweini R; Kim MM; Liu B; Zhu TC
    J Biophotonics; 2016 Dec; 9(11-12):1344-1354. PubMed ID: 27653233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and application of a physiologically based pharmacokinetic model for HPPH in rats and extrapolate to humans.
    Chen L; Zhang X; Cao Q; Wu Y; Zhang T; Tong H; Wang X; Yang J
    Eur J Pharm Sci; 2019 Mar; 129():68-78. PubMed ID: 30597205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gap junction enhances phototoxicity of photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH).
    Liu Z; Wang Q; Fan L; Wu DP; Zhang Y; Liu L; Tao L
    Lasers Surg Med; 2015 Jan; 47(1):68-76. PubMed ID: 25483871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy.
    Li G; Slansky A; Dobhal MP; Goswami LN; Graham A; Chen Y; Kanter P; Alberico RA; Spernyak J; Morgan J; Mazurchuk R; Oseroff A; Grossman Z; Pandey RK
    Bioconjug Chem; 2005; 16(1):32-42. PubMed ID: 15656573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase I Study of Light Dose for Photodynamic Therapy Using 2-[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a for the Treatment of Non-Small Cell Carcinoma In Situ or Non-Small Cell Microinvasive Bronchogenic Carcinoma: A Dose Ranging Study.
    Dhillon SS; Demmy TL; Yendamuri S; Loewen G; Nwogu C; Cooper M; Henderson BW
    J Thorac Oncol; 2016 Feb; 11(2):234-41. PubMed ID: 26718878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of photodynamic therapy with HPPH and gemcitabine in pancreatic cancer cell lines.
    Sun G; Anderson MA; Gorospe EC; Leggett CL; Lutzke LS; Wong Kee Song LM; Levy M; Wang KK
    Lasers Surg Med; 2012 Nov; 44(9):755-61. PubMed ID: 23018618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and comparison of three novel methods for the determination of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in human serum.
    Chen L; Xiao Q; Zhang X; Yang J
    J Pharm Biomed Anal; 2016 Mar; 121():13-21. PubMed ID: 26773535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy.
    Srivatsan A; Ethirajan M; Pandey SK; Dubey S; Zheng X; Liu TH; Shibata M; Missert J; Morgan J; Pandey RK
    Mol Pharm; 2011 Aug; 8(4):1186-97. PubMed ID: 21702452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.
    Bellnier DA; Henderson BW; Pandey RK; Potter WR; Dougherty TJ
    J Photochem Photobiol B; 1993 Sep; 20(1):55-61. PubMed ID: 8229470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole body and local hyperthermia enhances the photosensitizing efficacy of 3-[(1'-hexyloxy)ethyl]-3-Devinylpyropheophorbide-a (HPPH).
    Srivatsan A; Sen A; Cheruku RR; Missert JR; Durrani FA; Guru K; Pandey RK
    Lasers Surg Med; 2018 Jul; 50(5):506-512. PubMed ID: 29737551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity.
    Rigual N; Shafirstein G; Cooper MT; Baumann H; Bellnier DA; Sunar U; Tracy EC; Rohrbach DJ; Wilding G; Tan W; Sullivan M; Merzianu M; Henderson BW
    Clin Cancer Res; 2013 Dec; 19(23):6605-13. PubMed ID: 24088736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2.
    Liu W; Baer MR; Bowman MJ; Pera P; Zheng X; Morgan J; Pandey RA; Oseroff AR
    Clin Cancer Res; 2007 Apr; 13(8):2463-70. PubMed ID: 17438106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Explicit dosimetry for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a-mediated photodynamic therapy: macroscopic singlet oxygen modeling.
    Penjweini R; Liu B; Kim MM; Zhu TC
    J Biomed Opt; 2015; 20(12):128003. PubMed ID: 26720883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endobronchial photodynamic therapy for lung cancer.
    Loewen GM; Pandey R; Bellnier D; Henderson B; Dougherty T
    Lasers Surg Med; 2006 Jun; 38(5):364-70. PubMed ID: 16788932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.